Quintiles Partners with Leading Foundation Trust and University to Improve Patient Care and Drive Efficiency in Clinical Research

Guy`s and St Thomas` NHS Foundation Trust and King`s College London sign
collaborative agreement
LONDON--(Business Wire)--
A significant step in driving innovation, improving patient care and increasing
efficiency in early stage clinical research was taken today with the
announcement that two of the UK`s leading institutions - Guy`s and St Thomas`
NHS Foundation Trust and King`s College London - have signed a collaborative
agreement with Quintiles, the only fully integrated biopharmaceutical services
company offering clinical, commercial, consulting and capital solutions
worldwide.

As part of the agreement, Quintiles has commissioned a state of the art research
facility with 30 beds, for both patients and healthy volunteers involved in
research, on the 14th floor of Guy`s Hospital in central London. The facility,
to be completed in early 2010, will now be known as the Quintiles Drug Research
Unit at Guy`s Hospital. The facility significantly increases Quintiles` capacity
to conduct proof-of-concept programmes that help biopharmaceutical companies
develop better medicines faster.

"The biopharmaceutical industry must bring new drugs to market faster and with
greater predictability to address declining research and development
productivity," said Eddie Caffrey, Senior Vice President, Global Phase I,
Quintiles. "The smartest move is to invest in intelligent, early-stage
development because, when done well, it has significant impact on speed and cost
of the overall development process."

A further strength of the collaboration is that it will bring Quintiles
physically and professionally closer to academic and medical colleagues in the
Academic Health Sciences Centre (AHSC), King`s Health Partners, and its National
Institute for Health Research (NIHR) comprehensive Biomedical Research Centre
(BRC). The Quintiles Drug Research Unit at Guy`s Hospital will be perfectly
positioned next to leading-edge Clinical Research Facilities and a Good
Manufacturing Practice (GMP) Pharmacy currently being developed by Guy`s and St
Thomas` and King`s College London to drive forward the translation of science
onto the wards -from `bench to bedside` - and will also be adjacent to the home
of the BRC`s new Faculty of Translational Medicine.

Ron Kerr, Chief Executive of Guy`s and St Thomas` NHS Foundation Trust said: "We
want to deliver the best possible care to our patients, and we know that
aligning clinical service excellence with translational research has been shown
to be one of the most effective ways to do this. We`re excited by the potential
of this collaboration as it will lead to a smoother and faster clinical trials
process, ensuring our patients and local people are amongst the first to benefit
from any new discoveries."

Professor Robert Lechler, Vice-Principal (Health), King`s College London and
Director of King`s Health Partners, said: "King`s College London`s important
partnership with Quintiles and Guy`s and St Thomas` NHS Foundation Trust, one of
our Academic Health Sciences Centre (AHSC) partners, is exactly the sort of
collaboration we expect to see at the heart of King`s Health Partners. Through
this collaboration and the significant investments we have already made to
develop first class clinical research facilities, we will create a powerful
`experimental medicine` hub across four floors of the Guy`s Hospital Tower,
allowing us to harness the expertise of our world class scientists and
clinicians to drive new discoveries in medicine and clinical treatment."

The agreement between Quintiles, Guy`s and St Thomas` NHS Foundation Trust and
King`s College London was brokered by King`s Business, the innovation support
company for King's College London.

This expansion builds on Quintiles` existing, industry leading, network of Phase
I facilities across Europe, Asia and the US. Its experts and pioneers utilise
integrated data platforms comprising technically advanced electronic data
capture and reporting to facilitate early go/no-go decision making. This new
facility in Guy`s Hospital Tower, is an expansion of Quintiles existing
facilities in Newcomen Street.

About Quintiles

Quintiles is the only fully integrated biopharmaceutical services company
offering clinical, commercial, consulting and capital solutions worldwide. The
Quintiles network of 23,000 engaged professionals in more than 50 countries
around the globe works with an unwavering commitment to patients, safety and
ethics. Quintiles helps biopharmaceutical companies navigate risk and seize
opportunities in an environment where change is constant. For more information,
please visit www.quintiles.com.

About Guy`s and St Thomas` NHS Foundation Trust

Guy's and St Thomas' provides around 850,000 million patient contacts in acute
and specialist hospital services every year. As one of the biggest NHS Trusts in
the UK, it employs over 10,000 staff. The Trust works in partnership with the
Schools of Medicine, Dentistry, Nursing and Biomedical Sciences of King's
College London and other Higher Education Institutes to deliver high quality
education and research. Website: www.guysandstthomas.nhs.uk.

About King`s College London

King`s College London is one of the top 25 universities in the world (Times
Higher Education 2008) and the fourth oldest in England. A research-led
university based in the heart of London, King`s has 19,700 students from more
than 150 countries, and 5,400 employees. An investment of over £500 million has
been made in the redevelopment of its estate in recent years

About King`s Health Partners

King's College London and Guy's and St Thomas', King's College Hospital and
South London and Maudsley NHS Foundation Trusts are part of King`s Health
Partners.

King`s Health Partners Academic Health Sciences Centre (AHSC) is a pioneering
global collaboration between one of the world`s leading research-led
universities and three of London`s most successful NHS Foundation Trusts,
including leading teaching hospitals and comprehensive mental health services.

The driving purpose of King's Health Partners is to continually seek and bring
about swifter and more effective improvements in health and well-being for
patients in London and people everywhere. Combining the best of basic and
translational research, clinical excellence and world-class teaching to deliver
groundbreaking advances in physical and mental healthcare.

For more information, visit: www.kingshealthpartners.org

Quintiles
Charlotte Taylor, Media Relations
+44 1344 708386
media.info@quintiles.com
or
Greg Connors, Investor Relations
+ 919 998 2000
invest@quintiles.com
www.quintiles.com

Copyright Business Wire 2009